Anti‐prothrombin (anti‐PT) antibodies are recently identified antibodies directed toward a
phospholipid‐binding protein (prothrombin), which deserve attention for the reported clinical …

Antibodies against prothrombin are detected by enzyme immunoassays (EIA) in sera of
patients with antiphospholipid syndrome (APS). However, there are two methods for …

Antibodies against phospholipid-binding proteins, such as 2-glycoprotein I (2GPI) and
prothrombin, are associated with the clinical manifestations of the antiphospholipid …

Prothrombin (PT) provides one of the main antigenic targets of antiphospholipid antibodies
(aPL), the serologic markers of antiphospholipid syndrome (APS). First described in 1983 …

Research on antiphospholipid antibodies (aPL) and the thrombotic manifestations
associated with these antibodies has grown since the description of anticardiolipin …

According to the preliminary classification criteria of the antiphospholipid syndrome
(APS)(Sapporo Criteria), β2-glycoprotein I (β2GPI)-dependent anticardiolipin antibodies …

Antiprotrombin antibodies belong to the family of antiphospholipid antibodies (aPLs). The
clinical relevance of antiprothrombin antibodies has not been established and it depends on …

Objective: To evaluate the role of anti‐prothrombin (anti‐PT) antibodies in predicting
thrombosis in patients with systemic lupus erythematosus (SLE). Methods: An inception …

Lupus anticoagulant (LA) antibodies have been shown to be directed to protein-
phospholipid complexes. In this study, we report on LA antibodies from patients with the …

Since the discovery that antiphospholipid antibodies (aPL) bind to a cofactor at the
phospholipid membrane, the proteins beta-2-glycoprotein I (β2GPI) and prothrombin …